Clinical Trials Logo

Filter by:
NCT ID: NCT00906971 Completed - Clinical trials for Chronic Constipation

Physiotherapeutic Intervention in Children With Chronic Functional Constipation

Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether physiotherapy is effective in the treatment of the chronic functional constipation in children.

NCT ID: NCT00906594 Completed - Glaucoma Clinical Trials

Additive Intra-ocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% on Monotherapy With Latanoprost in Patients With Elevated Intra-ocular Pressure

Start date: September 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the additive effect of dorzolamide/timolol fixed combination in patients undergoing monotherapy with latanoprost.

NCT ID: NCT00906451 Completed - Clinical trials for Myocardial Infarction

Simvastatin Effect on Inflammation and Endothelial Function After Myocardial Infarction

Start date: November 2008
Phase: Phase 4
Study type: Interventional

During myocardial infarction, inflammatory response may negatively influence ventricle wall remodeling as well as endothelium-dependent vasomotor function in the coronary and systemic arterial systems. Statins have been consistently proved to attenuate inflammation and improve endothelial function. In this study, we tested the effect of different doses of statin on inflammatory response and endothelium-dependent vasodilation.

NCT ID: NCT00906139 Unknown status - Cirrhosis Clinical Trials

Propofol and Fentanyl Versus Midazolam and Fentanyl for Endoscopy Sedation in Cirrhotic Patients

Start date: March 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare propofol associated with fentanyl versus midazolam plus fentanyl for sedation during diagnosis or therapeutic upper gastrointestinal endoscopy (UGE) in cirrhotic patients.

NCT ID: NCT00905905 Completed - Clinical trials for Myocardial Infarction

Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction

Start date: May 2009
Phase: Phase 4
Study type: Interventional

During acute coronary syndromes (ACS), the generation of inflammatory mediators negatively influences arterial wall remodeling and the endothelium-dependent vasomotor function in the coronary and systemic arterial systems. In fact, the intensity of the inflammatory upregulation is strongly related to the incidence of recurrent coronary events. The investigators previously demonstrated that high dose potent statins can rapidly reduce plasma levels of cholesterol-rich lipoproteins and inflammatory activity in subjects during ACS. In addition, such statin treatment attenuates the post-discharge endothelial dysfunction of these patients. By inference, it is plausible to hypothesize that these beneficial effects during ACS may be intensified by an additive lowering of plasma cholesterol through the treatment with ezetimibe. So far, data is unavailable to verify this assumption. In parallel, data from animal models have suggested that both statins and ezetimibe may reduce insulin sensitivity by their effect on cholesterol content and, by this way, on insulin signaling in liver cells. In this context, the present study aims to investigate the role of the addition of ezetimibe upon statin treatment on stress-induced insulin resistance and on the time-course of the inflammatory response during the acute phase of myocardial infarction and its late effect on endothelium-dependent arterial dilation.

NCT ID: NCT00905775 Terminated - Coronary Disease Clinical Trials

Renal Function in Patients Submitted to Myocardial Revascularization Surgery

Start date: December 2008
Phase: N/A
Study type: Observational

Acute renal insufficiency (ARI) represents a frequent and serious complication in patients submitted to cardiac surgery, and is associated with increases in time of hospitalization, costs, morbidity and mortality. Its incidence varies from 3.5% to 31%. The present study aims to evaluate renal function and oxidative stress in patients submitted to revascularization surgery with extracorporeal circulation (ECC), comparing targeted venous anesthesia controlled with propofol and inhalational anesthesia with isoflurane.

NCT ID: NCT00905723 Unknown status - Clinical trials for Postmenopausal Symptoms

The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women

Start date: May 2009
Phase: Phase 3
Study type: Interventional

Climacterium is marked by hypoestrogenism and it is associated to drastic vasomotors symptoms, genital atrophy and humor alteration. Additionally, these symptoms impair sexual life and life quality. These effects can be counteracted by administration of estrogen therapy. However, estrogen therapy has side effects and isoflavone has been proposed as an estrogen substitute in reposition therapy. The aim of the randomized controlled trial is to evaluate the effects of isoflavone in the sex life assessed by a modified McCoy's sexual questionnaire.

NCT ID: NCT00905372 Completed - Alzheimer's Disease Clinical Trials

Effect of LY2062430 on the Progression of Alzheimer's Disease

EXPEDITION
Start date: May 2009
Phase: Phase 3
Study type: Interventional

Alzheimer's disease (AD) is an age-related degenerative disorder of the brain, characterized by progressive decline in cognitive function and ability to perform activities of daily living, and ultimately can lead to death due to complications of the disease. AD is thought to be caused by an excess of A-Beta amyloid, a sticky protein in the brain that forms amyloid plaques. Treatments that slow the synthesis or deposition of A-Beta amyloid, or that increase clearance, might be expected to slow the progression of AD. LY2062430 (solanezumab) is a humanized anti-A Beta peptide immunoglobulin G-1 (IgG1) monoclonal antibody being developed for the treatment of AD. The primary hypothesis being tested is that LY2062430 will slow cognitive and functional decline in AD as compared with placebo. Each patient's participation will last approximately 19 months. Patients taking approved AD medications may participate in this study and continue taking these medications during the study.

NCT ID: NCT00905333 Completed - Healthy Clinical Trials

Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal

Start date: October 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetic interaction of test formulations of candesartan and felodipine in a combination package comparing with the fasting intake of commercial formulations of both Atacand ® and Splendil®

NCT ID: NCT00905216 Recruiting - Cardiac Surgery Clinical Trials

Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to verify, through a randomized, single-blind, multicentre, parallel and comparative study, the effectiveness of heparin sodium of porcine origin in patients undergoing heart surgery that require the aid of cardiopulmonary bypass. The effectiveness will be determined through the control of hemostasis during and after surgery, based on the strengths of markers of coagulation trichloroacetic acid (TCA), alpha-tocopherol transfer protein (TTPA), Anti-Xa, heparin bioavailability and excessive loss of blood (bleeding) at the end of the surgery.